Sagacious Aldose Reductase Inhibition for Treatment of Metabolic Disorders. Journal of Carcinogenesis, [S. l.], v. 24, n. 9s, p. 410–418, 2025. DOI: 10.64149/J.Carcinog.24.9s.410-418. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/1503. Acesso em: 26 dec. 2025.